Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1740-1754

  Oura, T ^a   Yamashita, Kenichiro ^a   Suzuki, T ^a   Fukumori, D ^a   Watanabe, M ^a   Hirokata, G ^a   Wakayama, K ^a   Taniguchi, M ^a   Shimamura, T ^a   Miura, T ^b   Okimura, K ^b   Maeta, K ^b   Haga, H ^c   Kubota, K ^c   Shimizu, A ^d   Sakai, F ^e   Furukawa, H ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e ASTELLAS PHARMA INC   (Japan)

Author keywords

ASKP1240; CD40 CD154 costimulation blockade; Liver transplantation; Monoclonal antibody; Nonhuman primates

Indexed keywords

ASKP 1240; CD40 ANTIGEN; CD40 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HAPLORHINI; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; HUMANS; IMMUNOLOGIC MEMORY; LIVER TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MACACA FASCICULARIS; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84863190818     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04014.x     Document Type: Article

References (47)

1. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-1821.
2. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438. (Pubitemid 26162734)
3. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4-9. (Pubitemid 26033938)
4. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686-693. (Pubitemid 29289433)
5. Preston EH, Xu H, Dhanireddy KK, et al. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 2005; 5: 1032-1041. (Pubitemid 40571251)
6. Kanmaz T, Fechner JJ, Jr., Torrealba J, et al. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation 2004; 77: 914-920. (Pubitemid 38436834)
7. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med. 2000; 6: 114. (Pubitemid 30082329)
8. Andre P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002; 8: 247-252. (Pubitemid 34250102)
9. Haanstra KG, Ringers J, Sick EA, et al. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. Transplantation 2003; 75: 637-643. (Pubitemid 36337361)
10. Pearson TC, Trambley J, Odom K, et al. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 2002; 74: 933-940. (Pubitemid 35191239)
11. Imai A, Suzuki T, Sugitani A, et al. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys. Transplantation 2007; 84: 1020-1028. (Pubitemid 350287383)
12. Aoyagi T, Yamashita K, Suzuki T, et al. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: Induction and maintenance therapy. Am J Transplant 2009; 9: 1732-1741.
13. Nomura M, Yamashita K, Murakami M, et al. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation. Transplantation 2002; 73: 1403-1410. (Pubitemid 34547460)
14. Yamashita K, Masunaga T, Yanagida N, et al. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation 2003; 76: 1089-1096. (Pubitemid 37280839)
15. Chang GJ, Liu T, Feng S, et al. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery 2002; 132: 149-156. (Pubitemid 35024755)
16. Guillot C, Guillonneau C, Mathieu P, et al. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 2002; 168: 1600-1609. (Pubitemid 34135754)
17. Guillonneau C, Hill M, Hubert FX, et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 2007; 117: 1096-1106. (Pubitemid 46556766)
18. Monden M, Gotoh M, Kanai T, Valdivia LA, Umeshita K, Endoh W et al. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. Transplant Proc 1990; 22: 66-71. (Pubitemid 20112757)
19. Neuhaus P, Neuhaus R, Pichlmayr R, et al. An alternative technique of biliary reconstruction after liver transplantation. Res Exp Med (Berl) 1982; 180: 239-245. (Pubitemid 12085834)
20. Pitcher CJ, Hagen SI, Walker JM, et al. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002; 168: 29-43. (Pubitemid 34014099)
21. Koyama I, Nadazdin O, Boskovic S, et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007; 7: 1055-1061. (Pubitemid 46643090)
22. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection: An international panel. Hepatology 2000; 31: 792-799. (Pubitemid 30118655)
23. Frentsch M, Arbach O, Kirchhoff D, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005; 11: 1118-1124. (Pubitemid 41486836)
24. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 2005; 11: 1113-1117. (Pubitemid 41486835)
25. Ashokkumar C, Talukdar A, Sun Q, et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 2009; 9: 179-191.
26. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303. (Pubitemid 43355076)
27. Valujskikh A, Li XC. Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. J Am Soc Nephrol 2007; 18: 2252-2261. (Pubitemid 47203840)
28. Weaver TA, Charafeddine AH, Agarwal A, et al. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat Med 2009; 15: 746-749.
29. Taylor PA, Friedman TM, Korngold R, et al. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99: 4601-4609. (Pubitemid 34627233)
30. Pons JA, Revilla-Nuin B, Baroja-Mazo A, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008; 86: 1370-1378.
31. Turgeon NA, Kirk AD, Iwakoshi NN. Differential effects of donor-specific alloantibody. Transplant Rev 2009; 23: 25-33.
32. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665-673. (Pubitemid 36745238)
33. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582. (Pubitemid 32180027)
34. Martelius T, Halme L, Arola J, et al. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection. Transpl Immunol 2009; 21: 244-246.
35. Musat AI, Agni RM, Wai PY, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 1111; 11: 500-510.
36. Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46: 372-377.
37. Starzl TE. The "privileged" liver and hepatic tolerogenicity. Liver Transpl 2001; 7: 918-920.
38. Evans HM, Kelly DA, McKiernan PJ, et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117. (Pubitemid 43724635)
39. Cheng F, Li Y, Feng L, et al. Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplant Proc 2008; 40: 2167-2170.
40. Lee JK, Zaidi SH, Liu P, et al. A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis. Nat Med 1998; 4: 1383-1391. (Pubitemid 28553460)
41. Gotoh M, Monden M, Kanai T, et al. Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates. Transplant Proc 1991; 23: 3265-3268.
42. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay. Transplantation 2006; 82: 663-668. (Pubitemid 44395237)
43. Cooper RA. Hemolytic syndromes and red cell membrane abnormalities in liver disease. Semin Hematol 1980; 17: 103-112. (Pubitemid 10088065)
44. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2-17. (Pubitemid 30046812)
45. Quezada SA, Jarvinen LZ, Lind EF, et al. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22: 307-328. (Pubitemid 38680425)
46. Foy TM, Laman JD, Ledbetter JA, et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994; 180: 157-163. (Pubitemid 24181064)
47. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167-178.